Skip to Main Content

Paper Details

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance.
Hepatology Communications
4
2020
HCV, Hepatitis C Virus, NS3, NS3 RASs, NS3, NS5A, and NS5B regions, NS5A, NS5A RASs, NS5A region, NS5B, NS5B regions, RASs, Y93H, hepatitis, hepatitis C virus, patients, people, sofosbuvir
Author NameAffiliation
P Richard HarriganUniversity of British Columbia BC Canada.
  • 1 - 1

Datasets

Release 1.2